Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Seda Yilmaz-Elis"'
Autor:
Patrick S. Asmawidjaja, Cor Breukel, J. Sjef Verbeek, Erik Lubberts, Peter Boross, Sara M. Mangsbo, Javier Martin Ramirez, Jos van der Kaa, Maarten D. Brem, Conny Brouwers, A. Seda Yilmaz-Elis, Jill W. C. Claassens, Anne-Marie Mus
Publikováno v:
Journal of Immunology, 192(12), 5540-5547
Journal of Immunology, 192(12), 5540-5547. American Association of Immunologists
Journal of Immunology, 192(12), 5540-5547. American Association of Immunologists
Extensive analysis of a variety of arthritis models in germline KO mice has revealed that all four receptors for the Fc part of IgG (FcγR) play a role in the disease process. However, their precise cell type–specific contribution is still unclear.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fbf50cf133a8c8e6668f557e30aff42
https://doi.org/10.4049/jimmunol.1303272
https://doi.org/10.4049/jimmunol.1303272
Autor:
M. Edward Medof, Paul P. Tak, A. Seda Yilmaz-Elis, Kris A. Reedquist, J. Sjef Verbeek, Jörg Hamann, Daphne de Launay, Else N. Kop, Robert M. Hoek, Feng Lin
Publikováno v:
Arthritis and Rheumatism, 62, 4, pp. 1036-42
Arthritis and Rheumatism, 62, 1036-42
Arthritis and Rheumatism, 62, 1036-1042. John Wiley and Sons Inc.
Arthritis and rheumatism, 62(4), 1036-1042. John Wiley and Sons Inc.
Arthritis and Rheumatism, 62(4), 1036-1042
Arthritis and Rheumatism, 62, 1036-42
Arthritis and Rheumatism, 62, 1036-1042. John Wiley and Sons Inc.
Arthritis and rheumatism, 62(4), 1036-1042. John Wiley and Sons Inc.
Arthritis and Rheumatism, 62(4), 1036-1042
Contains fulltext : 88209.pdf (Publisher’s version ) (Closed access) OBJECTIVE: CD55 (decay-accelerating factor) is best known for its role in the negative regulation of the complement system. Indeed, lack of this molecule leads to disease aggravat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae3a044de04a8f968232c1ba618cf418
https://doi.org/10.1002/art.27347
https://doi.org/10.1002/art.27347
Autor:
A. Seda Yilmaz-Elis, J. Sjef Verbeek, Hans P. Kiener, Paul P. Tak, Marina Botto, Olga N. Karpus, Josef S Smolen, Valeria Ramaglia, Jörg Hamann, Birgit Niederreiter, Ramon Arens, Jos van der Kaa
Publikováno v:
Arthritis research & therapy, 17(1). BioMed Central
Arthritis Research & Therapy
Arthritis Research & Therapy
Introduction CD55, a glycosylphosphatidylinositol-anchored, complement-regulating protein (decay-accelerating factor), is expressed by fibroblast-like synoviocytes (FLS) with high local abundance in the intimal lining layer. We here explored the basi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1326353631ca43b88183d034d9927c97
https://hdl.handle.net/1887/104046
https://hdl.handle.net/1887/104046
Autor:
Judith C.T. van Deutekom, Gert-Jan B. van Ommen, Huma Safdar, Bart J.M. van Vlijmen, Peter A C 't Hoen, A. Seda Yilmaz-Elis, J. Sjef Verbeek, Annemieke Aartsma-Rus, Sjef J. de Kimpe, Cor Breukel
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 2, Iss C (2013)
Molecular Therapy. Nucleic Acids
Molecular Therapy. Nucleic Acids
The cytokine interleukin 1(IL-1) initiates a wide range of proinflammatory cascades and its inhibition has been shown to decrease inflammation in a variety of diseases. IL-1 receptor accessory protein (IL-1RAcP) is an indispensible part of the IL-1R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4efe1415ff6d9ae0607995eafb951002
http://www.sciencedirect.com/science/article/pii/S2162253116301263
http://www.sciencedirect.com/science/article/pii/S2162253116301263
Autor:
Annemieke Aartsma-Rus, Gert-Jan B. van Ommen, Anne Vroon, J. Sjef Verbeek, Sjef J. de Kimpe, Peter A C 't Hoen, Seda Yilmaz-Elis, Judith C.T. van Deutekom
Publikováno v:
Annals of the Rheumatic Diseases, 71, 75-77
Arthritis is an autoantibody-driven disease. Anti-CD20 treatment, removing B cells, treats the disease but introduces a new problem. This treatment removes B cells irrespective of their specificity, and thus attenuates the humoral response which migh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7986cdbe7821821b8c473073031fb30f
https://pubmed.ncbi.nlm.nih.gov/22460143
https://pubmed.ncbi.nlm.nih.gov/22460143
Autor:
A Seda, Yilmaz-Elis, J Sjef, Verbeek
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 867
Soluble receptors modify the biological response to ligand by competing with their membrane-bound counterparts for the ligand. They act as competitive inhibitors of the signaling by binding to ligands without inducing cellular signal transduction pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0e596218963ac9f3dcabb9f04bd4d458
https://pubmed.ncbi.nlm.nih.gov/22454064
https://pubmed.ncbi.nlm.nih.gov/22454064
Autor:
A. Seda Yilmaz-Elis, J. Sjef Verbeek
Publikováno v:
Methods in Molecular Biology ISBN: 9781617797668
Soluble receptors modify the biological response to ligand by competing with their membrane-bound counterparts for the ligand. They act as competitive inhibitors of the signaling by binding to ligands without inducing cellular signal transduction pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62b318be892684cabe7af6457e2195f9
https://doi.org/10.1007/978-1-61779-767-5_14
https://doi.org/10.1007/978-1-61779-767-5_14